Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Vericel (VCEL) over the last 14 years, with Sep 2025 value amounting to $305,000.

  • Vericel's Gains from Investment Securities rose 12.55% to $305,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 6.15%. This contributed to the annual value of $5.5 million for FY2024, which is 85.61% down from last year.
  • Latest data reveals that Vericel reported Gains from Investment Securities of $305,000 as of Q3 2025, which was up 124.26% from $136,000 recorded in Q2 2025.
  • In the past 5 years, Vericel's Gains from Investment Securities registered a high of $33.9 million during Q2 2023, and its lowest value of $7,000 during Q4 2022.
  • For the 3-year period, Vericel's Gains from Investment Securities averaged around $4.6 million, with its median value being $305,000 (2025).
  • As far as peak fluctuations go, Vericel's Gains from Investment Securities plummeted by 99.84% in 2021, and later spiked by 27,585.71% in 2023.
  • Over the past 5 years, Vericel's Gains from Investment Securities (Quarterly) stood at $46,000 in 2021, then slumped by 84.78% to $7,000 in 2022, then soared by 27,585.71% to $1.9 million in 2023, then plummeted by 92.11% to $153,000 in 2024, then increased by 12.55% to $305,000 in 2025.
  • Its Gains from Investment Securities was $305,000 in Q3 2025, compared to $136,000 in Q2 2025 and $6.2 million in Q1 2025.